Back
Autolus Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
59
AUTL
Autolus Therapeutics PLC
Last Price:
4.11
Seasonality Move:
9.81%
Buy
51
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.14
Seasonality Move:
3.75%
Buy
59
Autolus Therapeutics PLC (AUTL)
is a Buy
Is Autolus Therapeutics PLC a Buy, Sell or Hold?
- The current Autolus Therapeutics PLC [AUTL] share price is $4.11. The Score for AUTL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- AUTL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Adaptimmune Therapeutics PLC (ADAP)
is a Buy
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.14. The Score for ADAP is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ADAP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AUTL Stock Price Chart
What is Autolus Therapeutics PLC's stock price today?
-
The Autolus Therapeutics PLC share price today is $4.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
AUTL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 36.72 | Sell |
| Chaikin Money Flow: | 516141 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.01 - 5.17) | Sell |
| Bollinger Bands (100): | (4.88 - 6.62) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 46.44 | Sell |
| Chaikin Money Flow: | 937521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.28) | Sell |
| Bollinger Bands (100): | (0.79 - 1.47) | Buy |
AUTL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4 | Buy |
| 20-day SMA: | 4.38 | Sell |
| 50-day SMA: | 5.24 | Sell |
| 200-day SMA: | 4.46 | Sell |
| 8-day EMA: | 4.09 | Buy |
| 20-day EMA: | 4.41 | Sell |
| 50-day EMA: | 4.99 | Sell |
| 200-day EMA: | 4.63 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Sell |
| 20-day SMA: | 1.1 | Buy |
| 50-day SMA: | 1.33 | Sell |
| 200-day SMA: | 0.9 | Buy |
| 8-day EMA: | 1.14 | Buy |
| 20-day EMA: | 1.16 | Sell |
| 50-day EMA: | 1.21 | Sell |
| 200-day EMA: | 1.09 | Buy |
Autolus Therapeutics PLC Earnings Growth & AUTL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.03 per share, an increase this year of $0.34 per share, and an increase next year of $0.20 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.08 per share.
Autolus Therapeutics PLC Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||